Extracellular vesicles carrying cancer-associated signatures are central to Mercy BioAnalytics’ blood-based ovarian cancer screening approach, now advancing into a pivotal clinical validation study...
Read More »
Extracellular vesicles are being evaluated as stable blood-based biomarkers to support early ovarian cancer screening and improve detection before symptoms develop...
Read More »
Artificial intelligence combines exosomes, liquid biopsy, imaging, and clinical data to improve multi-cancer screening and support more personalized early cancer detection...
Read More »
A novel blood test using extracellular vesicles achieved 89% sensitivity and 98% specificity for early-stage ovarian cancer, offering a promising...
Read More »
The Destinex assay uses extracellular vesicles and microRNA biomarkers to enable highly accurate, minimally invasive early detection of gastric cancer, improving patient outcomes through timely...
Read More »
Liquid biopsy using serum breast milk and extracellular vesicles could help detect pregnancy-related breast cancer earlier, offering a non-invasive option for high-risk new mothers not covered by current screening programs...
Read More »
Illumina, Inc. and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, today announced they have entered into a definitive agreement under which Illumina will...
Read More »
IBM scientist Joshua Smith and his team developed a new lab-on-a-chip/nano-DLD technology that can separate biological particles which would be helpful to detect diseases like cancer at an early stage. The researchers at IBM have been working since last three years ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
